Pilot studies have indicated that single-cell omics (scOmics) approaches play an important role in studying the function of cells and revealing the difference between individual cells. Single-cell technologies can analyze the cell at different levels, including the genome, transcriptome, epigenome, as well as proteome. The results have been considered as critical data for analyzing disease biology and predicting the efficacy of novel drugs or therapies. With the extensive experiences and advanced platforms, Creative Biolabs has developed a wide variety of single-cell omics services to identify the role of immunity and microbiome in disease treatments, especially for cancer therapy.
|Single Cell Omics for microbiome genotypes|